midazolam + remifentanil

Midazolam + remifentanil is a combination of two intravenous drugs commonly used for procedural sedation and analgesia, particularly during brief or painful medical procedures. Midazolam is a short-acting benzodiazepine with sedative, anxiolytic, amnesic, muscle relaxant, and anticonvulsant properties. It acts by enhancing the effect of gamma-aminobutyric acid (GABA) at the GABA-A receptor in the central nervous system, leading to CNS depression[4][8][9]. Remifentanil is an ultra-short acting synthetic opioid analgesic that acts primarily as a mu-opioid receptor agonist to provide potent pain relief[10]. The combination leverages the rapid onset and offset of both agents to achieve deep sedation and effective analgesia with quick recovery times. However, this regimen carries significant risk for respiratory depression and requires close monitoring in controlled settings[2][6].